The M5076 tumor, a reticulum cell sarcoma of histiocytic origin that arose spontaneously in the ovary of a C57BL/6 mouse, is highly invasive and metastatic. Regardless of the site of the primary tumor, this neoplasm rapidly and preferentially metastasizes to the liver and spleen, killing the host. Numerous other organs also are involved, including the lungs and bone marrow. This tendency to metastasize to osseous tissues appears to be a characteristic of the M5076 tumor that rarely is found with other rodent neoplasms. However, these extrahepatic foci are evident only microscopically and are seen relatively late in the progression of tumor growth. We describe the sequential gross and microscopic lesions that develop in syngeneic mice during the metastatic spread of the M5076 tumor. Since viable tumor cells form small tumor colonies in most organs, we suggest that the gross pattern of metastasis, with the apparent predilection for hepatic tissue, is caused by variations in tumor cell proliferation rather than by distinctive patterns of neoplastic cell spread and entrapment.
Transplantable rodent neoplasms play an important role in experimental studies of cancer biology. The reproducibility and standardization of results obtained with transplantable tumors in syngeneic recipients are invaluable characteristics of these models. Unlike their counterparts in man, however, few of these rodent tumors spontaneously metastasize [ 11. Of the few transplantable rodent tumors that do metastasize, most form secondary tumor foci in the lungs and, unlike tumors in man, rarely colonize nonpulmonary sites [4] .
We recently have characterized the M5076 tumor as a murine reticulum cell sarcoma of histiocytic origin [21] . This tumor, which arose spontaneously in the ovary of a C57BL/6 mouse, selectively metastasizes to the peritoneal viscera regardless of the site of primary tumor growth. In contrast to other rodent tumors, the M5076 tumor rarely forms grossly evident lung metastases [8, lo] , but often metastasizes to the bone marrow. This distinctive pattern of tumor growth makes the M5076 tumor a useful model with which to study those processes that regulate the mechanisms of site-specific metastasis. Using histologic techniques, we have analyzed the sequence and nature of the metastatic spread of the M5076 tumor.
Materials and Methods
Mice: Specific-pathogen-free female mice of the inbred strain C57BL/6 were obtained from the NCI-Frederick Cancer Research Facility's Animal Production Area. Mice were six to eight weeks old at the start of the experiments.
Tumor cells: The M5076 tumor arose as a spontaneous tumor in the ovary of a C57BL/6 mouse in the laboratory of Dr. W. F. Dunning of the Papanicolaou Research Institute in Miami, Fla. We obtained the tumor, which had been cryopreserved following the 136th serial passage in syngeneic mice, from Dr. D. P. Griswold of the Southern Research Institute, Birmingham, Ala. The cultured tumor cells used in these experiments were examined and found free of Mycoplusmu and the following murine viruses: reovirus type 3, pneumonia virus of mice, K virus, Theiler's virus, Sendai virus, minute virus of mice, mouse adenovirus, mouse hepatitis virus, lymphocytic choriomeningitis virus, ectromelia virus and lactate dehydrogenase virus (M.A. Bioproducts, Walkersville, Md.).
Culture conditions: The M5076 cells were grown suspended in RPMI-1640 (Grand Island Biological Co., Grand Island, N.Y.) supplemented with 10% heat-inactivated equine serum (Flow Laboratories, Rockville, Md.), 2 mM glutamine, 1 mM sodium pyruvate, and 50 pg gentamicin/ml. The cells were subcultured weekly and incubated at 37°C in a humidified atmosphere of air and 5% COa as previously described [21] .
Tumor inoculation: Cells were harvested during mid log phase of growth by removing aliquots of the cell suspension and washing the cells twice in Hanks' balanced salt solution.
Viability was assessed by trypan blue exclusion, and only suspensions with > 90% viability were used. The tumor cell suspensions were adjusted to contain the appropriate number of viable cells per ml. A 0.05-ml inoculum was injected into the hind footpads of mice. In additional studies, a 0.1-ml inoculum also was injected intraperitoneally or subcutaneously, and the mice were allowed to survive as indicated in table I.
Necropsy: For studies on the sequential development of metastatic tumor foci, mice were killed at different time points with Metofane (Pitman-Moore, Inc., Washington Crossing, N.J.), and a complete necropsy was done. The following tissues were fmed routinely in buffered formalin for microscopic studies: tumor injection site; popliteal lymph node; lungs; liver; spleen; kidneys; ovaries; bones; vertebrae from the cervical, thoracic, abdominal and lumbar regions; femur; humerus; sternum; and skull. Any other tissues that appeared grossly to be involved also were prepared for microscopic examination. The osseous tissues were decalcified before tissue processing; routine paraffin sections were cut at 5 pm and stained with hematoxylin and eosin. At least ten isolated sections from each organ were examined to determine the incidence of micrometastasis.
Results

Mouse survival
The mean survival time of mice injected with M5076 tumor cells, which were obtained from tissue culture, is reported in table I. Death occurred rapidly in the hosts 31 to 42 days after tumor cells were injected into the peritoneal cavity or subcutaneously into the inguinal region. This survival time scarcely was affected by the size of the tumor cell inoculum. A reduction in the number of tumor cells injected subcutaneously from 10,000 to 10 cells resulted in an extension of host survival by only eight days. Implantation of tumor cells into the footpad resulted in an increased tumor induction period and an extended survival time. Comparable reductions in the number of tumor cells injected into the footpad to those injected into the subcutaneous site resulted in longer survival times; mice injected with 10,000 cells in the footpad lived for 52 days, whereas mice injected with ten cells lived for 73 days on the average (table I) .
Tumor-bearing mice became cachexic and emaciated before death. An occasional mouse had marked abdominal distension which was found, on necropsy, to be associated with hepatomegaly resulting from substantial secondary tumor growth ( fig. 1 ). Occasionally, we found paralysis of both hind legs in mice living for the longest periods of time after cell injection.
Tumor morphology
Gross appearance: At necropsy, characteristic gross lesions were evident as early as four to five weeks after the initial footpad tumor cell injection (table 11) . Generally, there was no evidence of tumor ulceration and the tumor appeared as a solid, uneven mass. Secondary tumors in the liver and spleen were evident as multiple, ovoid, discrete foci scattered throughout the parenchyma. The circumscribed, raised tumor deposits had an opalescent, grayish-white appearance and were distinguished easily from normal tissue. The hepatic metastatic tumor burden often appeared more Fig. 1 : Syngeneic C57BL/6 mouse with a primary intramuscular footpad tumor and marked hepatomegaly because of secondary tumor growth. Multiple, circumscribed tumor foci of differing size in the liver; hepatic tumor burden is greater than primary mass. Fig. 2 Typical focus of M5076 tumor cells resulting from metastasis by direct extension from a primary subcutaneous tumor (arrow). Tumor is located on serosal surface of stomach at junction of fore and glandular regions. Bar = 0.5 mm. extensive than that of the "primary" tumor ( fig. 1 ). In this study, no grossly apparent lung lesions were detected.
Subcutaneous tumors often invaded the peritoneal cavity by direct extension through the abdominal wall. When this occurred, there was extensive and generalized metastasis to the omentum and serosal surfaces of the viscera (fig. 2 ). Occasional ascites formation only was associated with subcutaneous, inguinal, or intraperitoneal tumor inoculation.
Histologic appearance: The most characteristic histologic feature of this tumor, regardless of the site of growth, was the striking degree of cellular pleomorphism. Cells exhibited a rounded, polygonal ( fig. 3) or spindle-shaped appearance ( fig. 4 ) with variable amounts of pale-staining cytoplasm showing marked vacuolation. This last feature was detected readily in impression smears of the liver ( fig. 5 ). Nuclei varied in size, were vesicular, and displayed single, prominent nucleoli. Numerous mitotic figures ( fig. 3 ) and bizarre multinucleated cells were scattered throughout all tumors. No cellular morphological differences were detected between tumors growing at the primary or secondary site.
Metastatic distribution
The results of a temporal study on the metastastic spread of the M5076 tumor are illustrated in table 11. The organ most commonly affected was the liver, followed by the spleen. During this study, no gross lung lesions were detected, but by 12 weeks after tumor cell injection, four out of five mice had microscopically evident pulmonary metastases. The bone marrow was also a common site of secondary tumor growth ( fig. 6 ). During the tenth to twelfth week following tumor implantation, microscopically detectable secondary bone marrow lesions were seen in the femur invaded from medullary cavity into meninges. Bar = 0.5 mm.
(69% of mice), humerus (50% of mice), vertebrae (63% of mice), sternum (44% of mice), and skull (32% of mice). Vertebral metastases occasionally extended from the medullary cavity into the meninges surrounding the spinal cord ( fig. 6 ). Tumor infiltration into the dorsal root ganglia also was observed occasionally in mice with vertebral involvement ( fig. 7) . No tumor growth was detected in the popliteal lymph node, although gross enlargement caused by lymphoid hyperplasia occurred in many mice.
Neoplastic lesions in parenchymal organs demonstrated an infiltrative as well as a nodular growth pattern, such that in many areas there was considerable intermixing between tumor cells and host tissue. The highest incidence of lung lesions occurred late in the third month after tumor injection, and the pulmonary metastases generally were centered around venules or veins ( fig. 8 ) and lymphatics or bronchioles. Tumor growth in the spleen was restricted to the red pulp and formed the same cellular patterns observed in the hepatic foci. In all sites, minimal host inflammatory infiltrates were evident histologically.
Discussion
We previously reported that the M5076 reticulum cell sarcoma exhibits a specific metastatic pattern regardless of the site of primary tumor growth. In these earlier studies grossly evident as well as microscopically evident pulmonary metastases were found rarely [lo] . We were able, however, to detect viable tumor cells in the lungs of mice with primary M5076 tumors using a bioassay in which small pieces of pulmonary tissue from mice bearing M5076 tumors were implanted subcutaneously into normal mice and subsequently developed into tumors [lo] . However, this bioassay failed to differentiate between tumor cells circulating intravascularly and latent or microscopic tumor foci. Therefore, a chronologic-histologic protocol was used in the present studies to examine the formation and incidence of extrahepatic metastatic lesions. Tumors were initiated from a small (1,000 cell) tumor inoculum to prolong the period of tumor induction and tumor growth. We report that, although the M5076 preferentially metastasized to the liver and spleen, the extended period of induction and growth allowed microscopic pulmonary lesions, as well as tumor foci in the bone marrow, to develop during the later course of tumor spread.
The extensive hepatic involvement seen here agrees with previous studies which have reported the liver and spleen to be common metastatic sites for reticulum cell sarcoma [l, 2, 7, 16, 171. However, in several other studies, pulmonary metastases also have been reported to occur from tumors of comparable origin [6, 121. In the present study, the pulmonary involvement was limited to microscopic lesions, suggesting that mice die of hepatic tumor burden before pulmonary metastases become detectable grossly.
These differences in the tumor burden of various organs appear to be related to differential rates of tumor growth, suggesting that the host organ may play a role in determining metastatic development [9] . Several possible explanations for the specific metastatic patterns displayed by many tumors have included organ vascularity [23] , specific arrest and entrapment of cells mediated via cell surface molecules [ 11, 141, mechanical trapping [3] , and the more generalized hypothesis that both host and tumor cell properties must be considered [9, 15, 181 . It appears from the results presented here that the M5076 tumor is capable of metastasizing to, lodging in, and growing in the lung, but that such growth is slower than hepatic tumor development.
The pattern of the lung lesions ( fig. 8 ) suggests either that metastases arise in the lung parenchyma after the initially lodged tumor cells have proliferated slowly within the lumen of blood vessels or that pulmonary metastatic foci are a consequence of tumor dissemination from established hepatic metastases.
Originally classified as an ovarian carcinoma on the basis of the tissue of origin and its histological appearance [ 191, the M5076 tumor subsequently was shown by functional and biochemical criteria to be of macrophage origin [21] . This macrophage origin also is suggested by the sites of metastatic development and the vacuolated and erythrophagocytic nature of the tumor cell cytoplasm (fig. 5 ). Other workers have suggested that host macrophages may limit the development of this tumor in pulmonary tissue and that, after administration of macrophage toxins to M5076 tumor-bearing, macrophage-depleted mice, gross pulmonary lesions were detected 1131. In our laboratory, the administration of the macrophage toxins silica or carrageenan to M5076 tumor-bearing mice did not result in a detectable increase in the number of lung metastases 21 days after the intravenous injection of M5076 cells, but resulted in a highly significant decrease in hepatic metastases. In one such experiment, the intravenous injection of 25,000 M5076 cells resulted in a median of 62 (range 12-126) hepatic tumor foci in control mice, whereas medians of 5 (0-13) and 0 (0-7) hepatic tumor foci were formed respectively in mice which were treated following tumor inoculation with silica or carrageenan. These data are consistent with the macrophage origin of this tumor, since the macrophage toxins not only eliminated host macrophages, but also were toxic to the M5076 cells. Host inflammatory infiltrates appeared minimal in histologic sections of primary or secondary tumors. These findings are in agreement with an earlier study which showed that the macrophage content of M5076 tumors was less than 5% [20] . From these observations, it appears unlikely that the macrophage content of M5076 tumors plays a significant role in determining patterns of metastatic development. Many transplantable rodent tumors do not metastasize via the lymphatics but are spread primarily via the hematogenous route [22] . The M5076 tumor would appear to belong to this category since we did not find any neoplastic lesions in the draining popliteal lymph node. Although direct invasion and penetration of the abdominal cavity by subcutaneous tumors accounted for some of the observed metastatic spread, the major route of tumor cell dissemination appears to be by hematogenous spread. Tumor cells are able to pass from the lymphatic system to the blood system with ease [5] , which means that classification of tumor dissemination by either the lymphatic or hematogenous route may be arbitrary [4] . Indeed, the proximity of M5076 pulmonary foci to the lung lymphatics and bronchiole-associated lymphoid tissue indirectly suggests that, at some point during the pathogenesis of metastasis, M5076 tumor cells travel via the lymphatic channels. The widespread dissemination of this tumor in the host suggests that the failure to grow in certain organs is unlikely to be ascribed to the lack of tumor cell spread and retention. Rather the grossly evident patterns of tumor development appear to be related to differences in preferential growth afforded by selected local environments [ 151. We conclude that the M5076 tumor system provides an excellent model to further study the nature of site-specific metastasis.
